Pain Medicine, Interventional Pain Medicine · Abilene, TX
NPI
1629015003
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2401 N Treadaway Blvd
Abilene, TX, 79601
Phone (325) 676-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$287K
32,032 services
Medicare patients, 2024
806
Average age 74
Drug cost, 2024
$283K
8,139 prescriptions
Company payments, 2025
$611
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Norman J Dozier was code J1010 (injection, methylprednisolone acetate, 1 mg), 16,020 times for 189 patients. In total Norman J Dozier billed 32,032 services in 55 codes, and Medicare paid $287K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 16,020 | 189 | $0.10 | $1,647 |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,600 | 22 | $4.94 | $52K |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 431 | 107 | $0.11 | $45.32 |
| 64483 Nerve Block Injection - Back | Facility | 372 | 179 | $84.36 | $31K |
| 62323 Nerve Block Injection - Back | Facility | 324 | 155 | $63.28 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 190 | 18 | $0.09 | $16.4 |
| 27096 Joint Injection | Facility | 173 | 92 | $66.26 | $11K |
| 99213 Office E&M - Established | Office | 172 | 143 | $51.87 | $8,922 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 156 | 83 | $4.52 | $705 |
| 62321 Nerve Block Injection - Back | Facility | 145 | 80 | $69.35 | $10K |
| 99203 Office E&M - New | Office | 136 | 136 | $70.67 | $9,612 |
| 64484 Nerve Block Injection - Back | Facility | 102 | 52 | $36.42 | $3,715 |
| 20610 Joint Injection | Office | 99 | 53 | $46.43 | $4,597 |
| 64483 Nerve Block Injection - Back | Office | 76 | 71 | $186.38 | $14K |
| 62323 Nerve Block Injection - Back | Office | 67 | 61 | $168.77 | $11K |
By year: 2022 $395K for 25,746 services; 2023 $334K for 18,465 services; 2024 $287K for 32,032 services.
Medicare prescription drug claims, 2024
In 2024, the drug Norman J Dozier prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,670 prescriptions and refills. In total Norman J Dozier wrote 8,139 Medicare prescriptions that cost $283K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,670 | 2,671 | 319 | $101K |
| Tramadol Hcl Generic | 1,159 | 1,179 | 177 | $17K |
| Gabapentin Generic | 1,057 | 1,183 | 185 | $16K |
| Pregabalin Generic | 530 | 579 | 112 | $8,362 |
| Fentanyl Generic | 487 | 488 | 47 | $54K |
| Tizanidine Hcl Generic | 477 | 553 | 84 | $7,911 |
| Methocarbamol Generic | 243 | 253 | 37 | $2,884 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 178 | 178 | 40 | $3,752 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 155 | 155 | 16 | $6,254 |
| Celecoxib Generic | 134 | 165 | 23 | $4,036 |
| Carisoprodol Generic | 125 | 131 | 16 | $946 |
| Zonisamide Generic | 123 | 150 | 26 | $2,023 |
| Oxycodone Hcl Generic | 105 | 105 | 13 | $1,916 |
| Duloxetine Hcl Generic | 81 | 117 | 12 | $1,287 |
| Meloxicam Generic | 79 | 121 | 19 | $344 |
Brand drugs: - claims; generic drugs: 8,101 claims; opioid claims: 4,886.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Norman J Dozier $611 ($611 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $521.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 22 | $521 |
| TerSera Therapeutics LLC | 3 | $90.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.